Find clinical trials for Heart Disease in Budapest, Budapest
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Heart Disease trials near Budapest, Budapest, HUN:
for the treatment of NYHA Class ≥ II patients with severe functional mitral regurgitation who are not suitable for surgical treatment following Heart...
Budapest, Hungary and 2 other locations
The goal of this clinical trial is to determine the clinical effect of orticumab treatment on inflammation in study participants with prior myocardia...
Phase 2
Budapest, Central Hungary, Hungary and 40 other locations
INTENSE Trial is a prospective, double-blind, randomized, placebo-controlled, single-center study with two arms (40 mg intensified statin therapy vs...
Budapest, Budapest, Hungary
TripleTRE investigates the effect of initial triple combination therapy (oral endothelin receptor antagonist (ERA) + oral phosphodiesterase tyüe-5 in...
Phase 4
Budapest, Hungary and 18 other locations
with placebo in participants with atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD). Participation...
Phase 3
Budapest, Hungary and 560 other locations
The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications o...
Phase 3
Budapest, Hungary and 765 other locations
The primary objective of this trial is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease...
Phase 3
Budapest, Hungary and 742 other locations
cardiovascular events (MACE) including coronary heart disease (CHD) death, ischemic stroke, myocardial infarction (MI), acute limb...
Phase 3
Budapest, Hungary and 673 other locations
with mild cognitive impairment (MCI) or mild to moderate Alzheimer's disease (AD). The study's primary focus is on safety and how the drug i...
Phase 2
Budapest, Hungary and 5 other locations
This is a pivotal phase III study designed to evaluate safety, tolerability, and efficacy of inclisiran in children (aged 6 to \<12 years) with heter...
Phase 3
Budapest, Hungary and 62 other locations
Clinical trials
Research sites
Resources
Legal